|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001128,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0030705,
umls-concept:C0033522,
umls-concept:C0034656,
umls-concept:C0038358,
umls-concept:C0079488,
umls-concept:C0087111,
umls-concept:C0332152,
umls-concept:C0358591,
umls-concept:C0549262
|
|
pubmed:issue |
91-92
|
|
pubmed:dateCreated |
2009-7-22
|
|
pubmed:abstractText |
Helicobacter pylori (H. pylori) eradication therapy increases acid secretion and promotes the development of gastroesophageal reflux disease (GERD) and reflux esophagitis (RE). Rebound acid hypersecretion develops after the use of proton pump inhibitors (PPI). We examined the clinical necessity of acid inhibitors to prevent GERD or RE caused by PPI rebound phenomenon and prior H. pylori eradication therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0172-6390
|
|
pubmed:author |
pubmed-author:ChayamaKazuakiK,
pubmed-author:ImagawaShinobuS,
pubmed-author:ItoMasanoriM,
pubmed-author:KitamuraShosukeS,
pubmed-author:MatsumotoYoshiakiY,
pubmed-author:TakamuraAkemiA,
pubmed-author:TakataShunsukeS,
pubmed-author:TanakaShinjiS,
pubmed-author:TatsugamiMasanaM,
pubmed-author:WadaYoshihiroY,
pubmed-author:YoshiharaMasaharuM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
624-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19621668-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:19621668-Adult,
pubmed-meshheading:19621668-Aged,
pubmed-meshheading:19621668-Aged, 80 and over,
pubmed-meshheading:19621668-Anti-Ulcer Agents,
pubmed-meshheading:19621668-Chalcones,
pubmed-meshheading:19621668-Cohort Studies,
pubmed-meshheading:19621668-Esophagitis, Peptic,
pubmed-meshheading:19621668-Gastroesophageal Reflux,
pubmed-meshheading:19621668-Helicobacter Infections,
pubmed-meshheading:19621668-Helicobacter pylori,
pubmed-meshheading:19621668-Humans,
pubmed-meshheading:19621668-Middle Aged,
pubmed-meshheading:19621668-Nizatidine,
pubmed-meshheading:19621668-Proton Pump Inhibitors,
pubmed-meshheading:19621668-Stomach Neoplasms,
pubmed-meshheading:19621668-Stomach Ulcer
|
|
pubmed:articleTitle |
Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.
|
|
pubmed:affiliation |
Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
